Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
A Standard patent application filed on 16 February 2000 credited to Stratz, Thomas ; Muller, Wolfgang

Details

Application number :

26725  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes  

Inventor :

Stratz, Thomas ; Muller, Wolfgang  

Agent name :

 

Address for service :

 

Filing date :

16 February 2000  

Associated companies :

 

Applicant name :

Novartis AG  

Applicant address :

 

Old name :

 

Original Source :

Go  

Same Inventor

• Use of serotonin antagonists (5HT3) for treating fibro myalgia